Overview
Human trabecular meshwork (HTM) cells are critical components of the eye’s drainage system, located in the anterior chamber angle. These cells form a porous network that controls the outflow of aqueous humor, thereby maintaining intraocular pressure (IOP). Dysfunction of HTM cells is linked to glaucoma, a leading cause of blindness. HTM cells are derived from neural crest origin and exhibit unique mechanosensitive properties. Researchers isolate them for in vitro studies to model glaucoma pathogenesis or test IOP-lowering drugs. Their procurement is essential for ophthalmology-focused biotech firms and academic labs.
Key Features
HTM cells are characterized by their ability to modulate extracellular matrix (ECM) composition, which directly impacts aqueous humor flow resistance. They express markers like α-smooth muscle actin and myocilin, making them identifiable in lab settings. These cells also demonstrate contractile behavior, influencing the trabecular meshwork’s stiffness. Advanced studies use 3D cultures or perfused systems to mimic physiological conditions, enabling better translational research outcomes.
Application Areas
Primary applications include glaucoma research, where HTM cells help elucidate mechanisms of elevated IOP and test novel therapeutics like Rho kinase inhibitors. They are also used in biocompatibility studies for intraocular devices. In tissue engineering, HTM cells are explored for constructing artificial drainage tissues. Their role in ECM remodeling makes them valuable for studying fibrosis and age-related ocular changes.
Precautions
Working with HTM cells demands strict aseptic techniques due to their sensitivity to contamination. Culture media must include growth factors like TGF-β to maintain phenotype. Cryopreserved cells should be thawed gradually to ensure viability. Ethical sourcing is critical; suppliers should provide donor consent documentation and health screening data. Researchers must validate cell functionality through assays like phagocytosis or ECM secretion tests.
B2B Procurement Guide
When procuring HTM cells, prioritize suppliers offering detailed COAs (Certificates of Analysis) with metrics like viability (>80%), endotoxin levels, and mycoplasma testing. Custom isolation services are available for specific donor criteria (e.g., age, disease status). Bulk purchases may qualify for discounts, but ensure batch-to-batch consistency. For long-term projects, consider establishing a partnership with specialized biobanks or academic spin-offs.